Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea
Reads0
Chats0
TLDR
In this paper, the authors used high-density Roche 454 pyrosequencing to survey the distal gut microbiota for 39 individuals with CDI, 36 subjects with C. difficile-negative nosocomial diarrhea (CDN), and 40 healthy control subjects.Abstract:
Clostridium difficile infection (CDI) causes nearly half a million cases of diarrhea and colitis in the United States each year. Although the importance of the gut microbiota in C. difficile pathogenesis is well recognized, components of the human gut flora critical for colonization resistance are not known. Culture-independent high-density Roche 454 pyrosequencing was used to survey the distal gut microbiota for 39 individuals with CDI, 36 subjects with C. difficile-negative nosocomial diarrhea (CDN), and 40 healthy control subjects. A total of 526,071 partial 16S rRNA sequence reads of the V1 to V3 regions were aligned with 16S databases, identifying 3,531 bacterial phylotypes from 115 fecal samples. Genomic analysis revealed significant alterations of organism lineages in both the CDI and CDN groups, which were accompanied by marked decreases in microbial diversity and species richness driven primarily by a paucity of phylotypes within the Firmicutes phylum. Normally abundant gut commensal organisms, including the Ruminococcaceae and Lachnospiraceae families and butyrate-producing C2 to C4 anaerobic fermenters, were significantly depleted in the CDI and CDN groups. These data demonstrate associations between the depletion of Ruminococcaceae, Lachnospiraceae, and butyrogenic bacteria in the gut microbiota and nosocomial diarrhea, including C. difficile infection. Mechanistic studies focusing on the functional roles of these organisms in diarrheal diseases and resistance against C. difficile colonization are warranted.read more
Citations
More filters
Journal ArticleDOI
Review article: the future of microbiome‐based therapeutics
Emily L. Gulliver,Remy B. Young,Michelle Chonwerawong,Gemma L. D’Adamo,Tamblyn Thomason,James T Widdop,Emily L. Rutten,Vanessa Rossetto Marcelino,Robert V Bryant,Samuel P Costello,Claire L. O'Brien,Georgina L. Hold,Edward M. Giles,Samuel C. Forster +13 more
TL;DR: In this paper , the health benefit of manipulating the human microbiota has been exploited for millennia, from consumption of fermented foods and probiotics to emerging applications of faecal microbiota transplantation, and recent technological advances are unlocking the capacity for targeted microbial manipulation as a novel therapeutic.
Journal ArticleDOI
Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
TL;DR: While FMT in ulcerative colitis appears promising, further studies on the durability and long-term safety are needed before it can be recommended in clinical practice.
Journal ArticleDOI
Copper Changes Intestinal Microbiota of the Cecum and Rectum in Female Mice by 16S rRNA Gene Sequencing
Sufang Cheng,Huirong Mao,Yezhao Ruan,Cong Wu,Zheng Xu,Guoliang Hu,Xiaoquan Guo,Caiying Zhang,Huabin Cao,Ping Liu +9 more
TL;DR: It is demonstrated that high concentrations of Cu could induce tissue injury and interrupt the homeostasis of microbiota.
Journal ArticleDOI
Characterization of Circulating Clostridium difficile Strains, Host Response and Intestinal Microbiome in Hospitalized Children With Diarrhea.
Emily A. Lees,Enitan D. Carrol,Nicholas Ellaby,Paul Roberts,Caroline E. Corless,Luca Lenzi,Alistair C. Darby,Sarah J. O'Brien,Nigel A. Cunliffe,Mark A. Turner,Fabio Miyajima,Munir Pirmohamed +11 more
TL;DR: Children with diarrhea regularly carried toxigenic and non-toxigenic strains of C. difficile, demonstrating enhanced microbiotal diversity, and change in milieu, without apparent morbidity.
Journal Article
Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results.
Elena Reigadas,María Olmedo,Maricela Valerio,S. Vázquez-Cuesta,Luis Alcalá,Mercedes Marín,Patricia Muñoz,Emilio Bouza +7 more
TL;DR: In this cohort, FMT proved to be safe and effective, even in high risk patients, and oral administration in capsules also proved to been safe, well-tolerated, and highly effective for R-CDI.
References
More filters
Journal ArticleDOI
Metagenomic biomarker discovery and explanation
Nicola Segata,Jacques Izard,Jacques Izard,Levi Waldron,Dirk Gevers,Larisa Miropolsky,Wendy S. Garrett,Curtis Huttenhower +7 more
TL;DR: A new method for metagenomic biomarker discovery is described and validates by way of class comparison, tests of biological consistency and effect size estimation to address the challenge of finding organisms, genes, or pathways that consistently explain the differences between two or more microbial communities.
Journal ArticleDOI
SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB
Elmar Pruesse,Christian Quast,Katrin Knittel,Bernhard M. Fuchs,Wolfgang Ludwig,Jörg Peplies,Frank Oliver Glöckner +6 more
TL;DR: SILVA (from Latin silva, forest), was implemented to provide a central comprehensive web resource for up to date, quality controlled databases of aligned rRNA sequences from the Bacteria, Archaea and Eukarya domains.
Journal ArticleDOI
The human microbiome project.
Peter J. Turnbaugh,Ruth E. Ley,Micah Hamady,Claire M. Fraser-Liggett,Rob Knight,Jeffrey I. Gordon +5 more
TL;DR: A strategy to understand the microbial components of the human genetic and metabolic landscape and how they contribute to normal physiology and predisposition to disease.
Journal ArticleDOI
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood,A. Vrieze,Max Nieuwdorp,Susana Fuentes,Erwin G. Zoetendal,Willem M. de Vos,Caroline E. Visser,Ed J. Kuijper,Peter Speelman,Josbert J. Keller +9 more
TL;DR: The infusion of donor feces was significantly more effective for the treatment of recurrent C. difficile infection than the use of vancomycin and patients showed increased fecal bacterial diversity, similar to that in healthy donors, with an increase in Bacteroidetes species and clostridium clusters IV and XIVa and a decrease in Proteobacteria species.
Journal ArticleDOI
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen,Dale N. Gerding,Stuart Johnson,Ciaran P. Kelly,Vivian G. Loo,L. Clifford McDonald,Jacques Pépin,Mark H. Wilcox +7 more
TL;DR: This guideline updates recommendations regarding epidemiology, diagnosis, treatment, and infection control and environmental management of Clostridium difficile.
Related Papers (5)
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.
Charlie G. Buffie,Vanni Bucci,Vanni Bucci,Richard R. Stein,Peter T. McKenney,Lilan Ling,Asia Gobourne,Daniel No,Hui Liu,Melissa A. Kinnebrew,Agnes Viale,Eric R. Littmann,Marcel R.M. van den Brink,Marcel R.M. van den Brink,Robert R. Jenq,Ying Taur,Chris Sander,Justin R. Cross,Nora C. Toussaint,Nora C. Toussaint,Joao B. Xavier,Joao B. Xavier,Eric G. Pamer,Eric G. Pamer +23 more
QIIME allows analysis of high-throughput community sequencing data.
J. Gregory Caporaso,Justin Kuczynski,Jesse Stombaugh,Kyle Bittinger,Frederic D. Bushman,Elizabeth K. Costello,Noah Fierer,Antonio Gonzalez Peña,Julia K. Goodrich,Jeffrey I. Gordon,Gavin A. Huttley,Scott T. Kelley,Dan Knights,Jeremy E. Koenig,Ruth E. Ley,Catherine A. Lozupone,Daniel McDonald,Brian D. Muegge,Meg Pirrung,Jens Reeder,Joel Sevinsky,Peter J. Turnbaugh,William A. Walters,Jeremy Widmann,Tanya Yatsunenko,Jesse R. Zaneveld,Rob Knight,Rob Knight +27 more